• Home
  • Pharmaceuticals and Healthcare
Black Friday and New year Campaign 30% to 50% Discount on all reports!
Global Radiation Oncology Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Radiation Oncology Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Report Code: KNJ1408757 | No. of Pages: 111 | Category: Pharmaceuticals and Healthcare
Publisher: Maia Research | Date of Publish: Sep-2022 
Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Radiation Oncology estimated at US$ 5777.1 million in the year 2022, is projected to reach a revised size of US$ 7830.8 million by 2028, growing at a CAGR of 5.2% during the forecast period 2022-2028.

The USA market for Radiation Oncology is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Radiation Oncology is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Radiation Oncology is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key companies of Radiation Oncology include Accuray, C. R. Bard, Elekta, IBA Worldwide, Varian Medical Systems, Carl Zeiss Meditec, iCAD, IsoRay and Mevion Medical Systems, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Radiation Oncology companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Radiation Oncology market. Further, it explains the major drivers and regional dynamics of the global Radiation Oncology market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Accuray

C. R. Bard

Elekta

IBA Worldwide

Varian Medical Systems

Carl Zeiss Meditec

iCAD

IsoRay

Mevion Medical Systems

Nordion

NTP Radioisotopes

Canon Medical Systems

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Radiation Oncology Segment by Type

External Beam Radiation Therapy (EBRT)

Brachytherapy

Radiation Oncology Segment by Application

Blood Cancer (Leukaemia)

Breast Cancer

Gastrointestinal Cancer

Respiratory/Lung Cancer

Skin Cancer

Other Cancers

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Radiation Oncology market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Radiation Oncology Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 External Beam Radiation Therapy (EBRT)

1.2.3 Brachytherapy

1.3 Market by Application

1.3.1 Global Radiation Oncology Market Growth Rate by Application: 2017 VS 2021 VS 2028

1.3.2 Blood Cancer (Leukaemia)

1.3.3 Breast Cancer

1.3.4 Gastrointestinal Cancer

1.3.5 Respiratory/Lung Cancer

1.3.6 Skin Cancer

1.3.7 Other Cancers

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global Radiation Oncology Market Size (2017-2028)

2.2 Radiation Oncology Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.3 Global Radiation Oncology Market Size by Region (2017-2022)

2.4 Global Radiation Oncology Market Size Forecast by Region (2023-2028)

2.5 Global Top Radiation Oncology Countries Ranking by Market Size

3 Radiation Oncology Competitive by Company

3.1 Global Radiation Oncology Revenue by Players

3.1.1 Global Radiation Oncology Revenue by Players (2017-2022)

3.1.2 Global Radiation Oncology Market Share by Players (2017-2022)

3.2 Global Radiation Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Company Covered: Ranking by Radiation Oncology Revenue

3.4 Global Radiation Oncology Market Concentration Ratio

3.4.1 Global Radiation Oncology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Radiation Oncology Revenue in 2021

3.5 Global Radiation Oncology Key Players Head office and Area Served

3.6 Key Players Radiation Oncology Product Solution and Service

3.7 Date of Enter into Radiation Oncology Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Global Radiation Oncology Breakdown Data by Type

4.1 Global Radiation Oncology Historic Revenue by Type (2017-2022)

4.2 Global Radiation Oncology Forecasted Revenue by Type (2023-2028)

5 Global Radiation Oncology Breakdown Data by Application

5.1 Global Radiation Oncology Historic Market Size by Application (2017-2022)

5.2 Global Radiation Oncology Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Radiation Oncology Revenue by Company (2020-2022)

6.2 North America Radiation Oncology Revenue by Type (2017-2028)

6.3 North America Radiation Oncology Revenue by Application (2017-2028)

6.4 North America Radiation Oncology Revenue by Country (2017-2028)

6.4.1 U.S.

6.4.2 Canada

7 Europe

7.1 Europe Radiation Oncology Revenue by Company (2020-2022)

7.2 Europe Radiation Oncology Revenue by Type (2017-2028)

7.3 Europe Radiation Oncology Revenue by Application (2017-2028)

7.4 Europe Radiation Oncology Revenue by Country (2017-2028)

7.4.1 Germany

7.4.2 France

7.4.3 U.K.

7.4.4 Italy

7.4.5 Russia

8 Asia Pacific

8.1 Asia Pacific Radiation Oncology Revenue by Company (2020-2022)

8.2 Asia Pacific Radiation Oncology Revenue by Type (2017-2028)

8.3 Asia Pacific Radiation Oncology Revenue by Application (2017-2028)

8.4 Asia Pacific Radiation Oncology Revenue by Region (2017-2028)

8.4.1 China

8.4.2 Japan

8.4.3 South Korea

8.4.4 India

8.4.5 Australia

8.4.6 Taiwan

8.4.7 Indonesia

8.4.8 Thailand

8.4.9 Malaysia

8.4.10 Philippines

8.4.11 Vietnam

9 Latin America

9.1 Latin America Radiation Oncology Revenue by Company (2020-2022)

9.2 Latin America Radiation Oncology Revenue by Type (2017-2028)

9.3 Latin America Radiation Oncology Revenue by Application (2017-2028)

9.4 Latin America Radiation Oncology Revenue by Country (2017-2028)

9.4.1 Mexico

9.4.2 Brazil

9.4.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Radiation Oncology Revenue by Company (2020-2022)

10.2 Middle East and Africa Radiation Oncology Revenue by Type (2017-2028)

10.3 Middle East and Africa Radiation Oncology Revenue by Application (2017-2028)

10.4 Middle East and Africa Radiation Oncology Revenue by Country (2017-2028)

10.4.1 Turkey

10.4.2 Saudi Arabia

10.4.3 UAE

11 Company Profiles

11.1 Accuray

11.1.1 Accuray Company Details

11.1.2 Accuray Business Overview

11.1.3 Accuray Radiation Oncology Products and Services

11.1.4 Accuray Radiation Oncology Revenue in Radiation Oncology Business (2017-2022)

11.1.5 Accuray Radiation Oncology SWOT Analysis

11.1.6 Accuray Recent Developments

11.2 C. R. Bard

11.2.1 C. R. Bard Company Details

11.2.2 C. R. Bard Business Overview

11.2.3 C. R. Bard Radiation Oncology Products and Services

11.2.4 C. R. Bard Radiation Oncology Revenue in Radiation Oncology Business (2017-2022)

11.2.5 C. R. Bard Radiation Oncology SWOT Analysis

11.2.6 C. R. Bard Recent Developments

11.3 Elekta

11.3.1 Elekta Company Details

11.3.2 Elekta Business Overview

11.3.3 Elekta Radiation Oncology Products and Services

11.3.4 Elekta Radiation Oncology Revenue in Radiation Oncology Business (2017-2022)

11.3.5 Elekta Radiation Oncology SWOT Analysis

11.3.6 Elekta Recent Developments

11.4 IBA Worldwide

11.4.1 IBA Worldwide Company Details

11.4.2 IBA Worldwide Business Overview

11.4.3 IBA Worldwide Radiation Oncology Products and Services

11.4.4 IBA Worldwide Radiation Oncology Revenue in Radiation Oncology Business (2017-2022)

11.4.5 IBA Worldwide Radiation Oncology SWOT Analysis

11.4.6 IBA Worldwide Recent Developments

11.5 Varian Medical Systems

11.5.1 Varian Medical Systems Company Details

11.5.2 Varian Medical Systems Business Overview

11.5.3 Varian Medical Systems Radiation Oncology Products and Services

11.5.4 Varian Medical Systems Radiation Oncology Revenue in Radiation Oncology Business (2017-2022)

11.5.5 Varian Medical Systems Radiation Oncology SWOT Analysis

11.5.6 Varian Medical Systems Recent Developments

11.6 Carl Zeiss Meditec

11.6.1 Carl Zeiss Meditec Company Details

11.6.2 Carl Zeiss Meditec Business Overview

11.6.3 Carl Zeiss Meditec Radiation Oncology Products and Services

11.6.4 Carl Zeiss Meditec Radiation Oncology Revenue in Radiation Oncology Business (2017-2022)

11.6.5 Carl Zeiss Meditec Radiation Oncology SWOT Analysis

11.6.6 Carl Zeiss Meditec Recent Developments

11.7 iCAD

11.7.1 iCAD Company Details

11.7.2 iCAD Business Overview

11.7.3 iCAD Radiation Oncology Products and Services

11.7.4 iCAD Radiation Oncology Revenue in Radiation Oncology Business (2017-2022)

11.7.5 iCAD Radiation Oncology SWOT Analysis

11.7.6 iCAD Recent Developments

11.8 IsoRay

11.8.1 IsoRay Company Details

11.8.2 IsoRay Business Overview

11.8.3 IsoRay Radiation Oncology Products and Services

11.8.4 IsoRay Radiation Oncology Revenue in Radiation Oncology Business (2017-2022)

11.8.5 IsoRay Radiation Oncology SWOT Analysis

11.8.6 IsoRay Recent Developments

11.9 Mevion Medical Systems

11.9.1 Mevion Medical Systems Company Details

11.9.2 Mevion Medical Systems Business Overview

11.9.3 Mevion Medical Systems Radiation Oncology Products and Services

11.9.4 Mevion Medical Systems Radiation Oncology Revenue in Radiation Oncology Business (2017-2022)

11.9.5 Mevion Medical Systems Radiation Oncology SWOT Analysis

11.9.6 Mevion Medical Systems Recent Developments

11.10 Nordion

11.10.1 Nordion Company Details

11.10.2 Nordion Business Overview

11.10.3 Nordion Radiation Oncology Products and Services

11.10.4 Nordion Radiation Oncology Revenue in Radiation Oncology Business (2017-2022)

11.10.5 Nordion Radiation Oncology SWOT Analysis

11.10.6 Nordion Recent Developments

11.11 NTP Radioisotopes

11.11.1 NTP Radioisotopes Company Details

11.11.2 NTP Radioisotopes Business Overview

11.11.3 NTP Radioisotopes Radiation Oncology Products and Services

11.11.4 NTP Radioisotopes Radiation Oncology Revenue in Radiation Oncology Business (2017-2022)

11.11.5 NTP Radioisotopes Recent Developments

11.12 Canon Medical Systems

11.12.1 Canon Medical Systems Company Details

11.12.2 Canon Medical Systems Business Overview

11.12.3 Canon Medical Systems Radiation Oncology Products and Services

11.12.4 Canon Medical Systems Radiation Oncology Revenue in Radiation Oncology Business (2017-2022)

11.12.5 Canon Medical Systems Recent Developments

12 Radiation Oncology Market Dynamics

12.1 Radiation Oncology Market Trends

12.2 Radiation Oncology Market Drivers

12.3 Radiation Oncology Market Challenges

12.4 Radiation Oncology Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com